Medical Developments International Limited (MVP) is a Company engaged in delivering emergency medical solutions. The Company manufactures and distributes Penthrox, a fast-acting trauma and emergency pain relief product, used in hospital emergency departments, ambulance services, sports medicine and for analgesia during short surgical procedures.
Find out what a historical investment in Medical Developments International would be worth today using our MVP stock calculator.
Buying MVP shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Medical Developments International in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in MVP
What is the ticker symbol of Medical Developments International?
The ticker symbol for Medical Developments International is MVP.
How much is one share of MVP?
One share of MVP is valued at $0.43 as of 22 November 2026.
What is the market capitalisation of Medical Developments International MVP?
As of 22 November 2026 Medical Developments International has a market cap of $47.88M.
What is the P/E ratio of MVP?
The Price to Earnings ratio of MVP is 77.36.
What is the Earnings Per Share of MVP?
The Earnings Per Share of MVP is $0.01.
What is the 52-week high for Medical Developments International stock?
The Medical Developments International 52-week high stock price is $0.59.
What is the 52-week low for Medical Developments International stock?
The Medical Developments International 52-week low stock price is $0.37.
Can I buy MVP shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MVP shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.